Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin versus crystalloid for emergency department septic shock resuscitation
ACTRN12611000453987Phase 4Withdrawn
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) in septic shock (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoint: Organ dysfunction. Planned start Jun 2011; status: withdrawn.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on ACTRN12611000453987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000453987.